Jefferies Starts Noodles & Co. (NDLS) at Hold, $40 PT
Tweet
Share
E-mailGet Alerts NDLS Hot Sheet
Price: $15.03 -0.13%
Rating Summary:
6 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
6 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Jefferies initiates coverage on recent IPO Noodles & Co. (NASDAQ: NDLS) with a Hold. PT $40.00.
The analyst comments, "Noodles & Company should consistently grow EPS 25% going forward as it emerges as a national fast-casual brand. We find the business model, growth and management very attractive, but believe the stock already anticipates much of this at current industry-leading valuations. Thus, we introduce coverage with a Hold rating and $40 PT.
NOTE: Jefferies was a book-runner on the company's recent $100 mm IPO."
For an analyst ratings summary and ratings history on Noodles & Co. click here. For more ratings news on Noodles & Co. click here.
Shares of Noodles & Co. closed at $42.70 yesterday.
The analyst comments, "Noodles & Company should consistently grow EPS 25% going forward as it emerges as a national fast-casual brand. We find the business model, growth and management very attractive, but believe the stock already anticipates much of this at current industry-leading valuations. Thus, we introduce coverage with a Hold rating and $40 PT.
NOTE: Jefferies was a book-runner on the company's recent $100 mm IPO."
For an analyst ratings summary and ratings history on Noodles & Co. click here. For more ratings news on Noodles & Co. click here.
Shares of Noodles & Co. closed at $42.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Noodles & Company (NDLS) files $100M mixed shelf
- TD Cowen Assumes Sana Biotechnology (SANA) at Buy
- DA Davidson Starts Everus (ECG) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
